医学分子生物学杂志 ›› 2023, Vol. 20 ›› Issue (6): 536-539.doi: 10.3870/j.issn.1672-8009.2023.06.012

• 综述 • 上一篇    下一篇

FK506 结合蛋白样蛋白在疾病中的作用的研究进展 #br#

  

  1. 中国医科大学附属盛京医院 沈阳市, 110000
  • 出版日期:2023-11-30 发布日期:2023-12-28
  • 基金资助:
    辽宁省自然科学基金指导计划(No. 2019-ZD-0738)

Advances in Research on FKBPL in Diseases #br#

  1. Shengjing Hospital Affiliated to China Medical University, Shenyang, 110000, China
  • Online:2023-11-30 Published:2023-12-28

摘要: FK506 结合蛋白样蛋白 (FK506-binding protein like, FKBPL) 是亲免素家族的一员, 其功能十分广泛, 可以调控类固醇受体的信号转导, 抑制肿瘤干细胞及肿瘤细胞的生长, 并且能够作为肿瘤预后的生物学标志物最新研究发现, 它的 N 端区域存在抗血管生成结构域, 可在体内和体外发挥抗血管生成作用此外, FKBPL 还与炎症眼部疾病心理疾病等诸多问题相关文章主要从 FKBPL 的结构和功能出发, FKBPL 的功能研究进展进行综述, 并探讨其在临床应用中的前景

关键词:

FK506 结合蛋白样蛋白, 血管生成, 肿瘤, 内分泌

Abstract: FK506-binding protein like ( FKBPL) is a member of the immunophilin family,and its functions are highly diverse. It can regulate the signal transduction of steroid receptors, inhibit the growth of tumor stem cells and tumor cells, and serve as a biological marker for tumor prognosis. Recent research has revealed the presence of an anti-angiogenesis domain in the N-terminal region of FKBPL, indicating its role in regulating angiogenesis both in vivo and in vitro. Additionally, FKBPL is associated with various issues such as inflammation, ocular diseases,and psychological disorders. This review aims to make a summary of the recent researches on FKBPL from the aspects of its structure and functions, and discusses its potential clinical applications.

Key words: FK506-binding protein like, angiogenesis, tumor, endocrine

中图分类号: